Skip to Main Content

Paper Details

The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease.
Alzheimers Dement
42
2023
Author NameAffiliation
Reisa A SperlingBrigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School
Michael C DonohueAlzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern California
Sarah WalterAlzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern California
Keith A JohnsonBrigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School
Paul S AisenAlzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern California
  • 1 - 5

Datasets